Complex I and Parkinson's disease

IUBMB Life

Volumn 52, Issue 3-5, 2001, Pages 135-141

  Greenamyre, J T ^a   Sherer, T B ^a   Betarbet, R ^a   Panov, A V ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; PROTEIN SUBUNIT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; UBIQUINONE;

CELL DEATH; ELECTRON TRANSPORT; ENZYME DEFECT; ENZYME INHIBITION; ENZYME MECHANISM; HUMAN; MAMMAL; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; PARKINSON DISEASE; PATHOGENESIS; PROTON TRANSPORT; REVIEW;

MAMMALIA;

EID: 0036138997     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540152845939     Document Type: Review

References (39)

1. The mitochondrial electron transport and oxidative phosphorylation system
2. The NADH:ubiquinone oxidoreductase (complex I) of respiratory chains
3. Human mitochondrial complex I in health and disease
4. Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation by electron flow through the respiratory chain complex I
5. Rotenone inhibits the mitochondrial permeability transition-induced cell death in U937 and KB cells
6. GRIM-19, a cell death regulatory gene product, is a subunit of bovine mitochondrial NADH:ubiquinone oxidoreductase (complex I)
7. Problems with the biochemical diagnosis in mitochondrial (encephalo-)myopathies
8. Quinone specificity of complex I
9. Threshold effects in synaptosomal and nonsynaptic mitochondria from hippocampal CA1 and paramedian neocortex brain regions
10. Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration
11. 3H]dihydrorotenone binding to NADH:ubiquinone reductase (complex I) of the electron transport chain: An autoradiographic study
12. 3H]dihydrorotenone
13. Privileged access to mitochondria of calcium influx through N-methyl-D-aspartate receptors
14. Human complex I deficiency: Clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect
15. The permeability transition pore as a mitochondrial calcium release channel: A critical appraisal
16. Interaction of alpha-phenyl-N-tert-butyl nitrone and alternative electron acceptors with complex I indicates a substrate reduction site upstream from the rotenone binding site
17. Chronic systemic pesticide exposure reproduces features of Parkinson's disease
18. Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation
19. Oxidative stress and genetics in the pathogenesis of Parkinson's disease
20. Parkinson disease in twins: An etiologic study
21. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
22. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
23. Epidemiology of Parkinson's disease and akinetic syndromes
24. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease
25. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
26. The etiology of Parkinson's disease with emphasis on the MPTP story
27. Mitochondrial complex I deficiency in Parkinson's disease
28. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease
29. Abnormalities of the electron transport chain in idiopathic Parkinson's disease
30. Platelet mitochondrial function in Parkinson's disease
31. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease
32. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease
33. Origin and functional consequences of the complex I defect in Parkinson's disease
34. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease
35. Complex I inhibitors as insecticides and acaricides
36. Welding-related parkinsonism: Clinical features, treatment, and pathophysiology
37. Vulnerability of mitochondrial complex I in PC12 cells exposed to manganese
38. Manganese and calcium transport in mitochondria: Implications for manganese toxicity
39. Inhibitors of NADH-ubiquinone reductase: An overview